Table IV.
| |||||
---|---|---|---|---|---|
Inhibitor/Substrate | Ki (μM)a | Km (μM)b | Vmax (nmols/mg.min)b | Km,DA/Kic | |
MPP+ Derivatives | |||||
15 | MPP+I− | 92 ± 14 | 73 ± 11 | 1.4 ± 0.1 | 0.3 |
38 | 2′-MeMPP+I− | 95 ± 10 | 0.3 | ||
39 | 3′-OHMPP+I− | 2.4 ± 0.1 | 8.4 ± 2.1 | 1.9 ± 0.1 | 9.7 |
40 | 4′-OHMPP+I− | 82 ± 11 | 107 ± 16 | 1.6 ± 0.1 | 0.7 |
41 | 4′-OMeMPP+I− | 106 ± 14d | 135 ± 9 | 1.6 ± 0.1 | 0.2 |
42 | 3-Me 4-‘OHMPP+I− | 65 ± 19d | 0.8 | ||
43 | 4′-FMPP+I− | 51.3 ± 6.3d | 1.0 | ||
44 | 4′-ClMPP+I− | 7.6 ± 0.7 | 5.8 | ||
45 | 3′-ClMPP+I− | 46.3 ± 5.4d | 1.1 | ||
46 | 4′-CF3MPP+I− | 33.8 ± 4.2d | 1.3 | ||
47 | 3′-CF3MPP+I− | 24.6 ± 3.0d | 1.8 | ||
48 | 4′-CH3MPP+I− | 51.8 ± 8.7 | 41.3 ± 6.6 | 0.9 ± 0.1 | 1.0 |
49 | 4′-OHN3PP+I− | 338 ± 142 | 0.1 | ||
50 | 3′-OHN3PP+I− | 36.6 ± 4.3d | 1.2 | ||
MPTP Derivatives | |||||
51 | MPTPHCl | 52.5 ± 6.3 | 409 ± 88 | 1.7 ± 0.3 | 0.5 |
52 | 2′-MeMPTPHCl | 38.4 ± 5.2 | 0.7 | ||
53 | 2′-NH2MPTPHCl | 193 ± 39d | 0.1 | ||
54 | 3′-OHMPTP HCl | 25.8 ± 3.1d | 1.7 | ||
55 | 4′-OHMPTP HCl) | 134 ± 24d | 0.3 | ||
56 | 3′-ClMPTP HCl | 27.7 ± 3.4 | 1.6 | ||
57 | 4′-F MPTP HCl | 49.7 ± 6.3d | 0.9 | ||
58 | MPDP+ClO4− | 53.0 ± 13.6d | 0.7 |
Determined with resealed granule ghosts using DA as the substrate in the presence of 10 mM ATP, at pH 7.2.
Determined from initial rate uptake data under the same conditions;
Included for comparison purposes.
Estimated from a set of single inhibitor concentration data set (for further details see ref. 55).